SCHEMBL18054752

SCHEMBL18054752

CC(=O)CNC(=O)c1ccc(C2=NOC(c3cc(Cl)cc(C(F)(F)F)c3)(C(F)(F)F)C2)c2ccccc12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 5/20 0.33
P2RX1 P51575 1/20 0.33
TMPRSS4 Q9NRS4 1/20 0.33
LMNA P02545 3/20 0.33
HPGD P15428 2/20 0.33
CCR1 P32246 3/20 0.32
ACLY P53396 2/20 0.32
GAA P10253 2/20 0.32
POLB P06746 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
DDR1 Q08345 3/20 0.31
RAPGEF3 O95398 1/20 0.31
GPR52 Q9Y2T5 1/20 0.30
MEN1 O00255 2/20 0.30
PLA2G1B P04054 2/20 0.30
KMT2A Q03164 2/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3107673 0.93 MRGPRX4 (0.36) TACR1P2RX1TMPRSS4LMNAHPGD
SCHEMBL29039019 0.92 TACR1 (0.33) TACR1P2RX1TMPRSS4LMNAHPGD
SCHEMBL3099384 0.91 TACR1 (0.32) TACR1P2RX1TMPRSS4LMNAHPGD
SCHEMBL3104661 0.90 FAP (0.35) TACR1P2RX1TMPRSS4LMNAHPGD
Esafoxolaner SCHEMBL18054742 0.90 PTGES (0.33) TACR1P2RX1TMPRSS4LMNAHPGD
Afoxolaner SCHEMBL18054743 0.90 PTGES (0.33) TACR1P2RX1TMPRSS4LMNAHPGD
Afoxolaner SCHEMBL29367347 0.90 PTGES (0.33) TACR1P2RX1TMPRSS4LMNAHPGD
Afoxolaner SCHEMBL119580 0.90 PTGES (0.33) TACR1P2RX1TMPRSS4LMNAHPGD
Esafoxolaner SCHEMBL29413811 0.90 PTGES (0.33) TACR1P2RX1TMPRSS4LMNAHPGD
Afoxolaner SCHEMBL29358921 0.90 PTGES (0.33) TACR1P2RX1TMPRSS4LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016138339-A1 LONG-ACTING INJECTABLE FORMULATIONS COMPRISING AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES THEREOF MERIAL, INC. (US) 2016-09-01 WO disclosed